Outcome of Renal Allograft in Turkish Patients With Pretransplantation Hepatitis C Virus Infection

Transplantation Proceedings

Volumn 38, Issue 10, 2006, Pages 3448-3450

  Unal, E ^a   Turkmen, F ^a   Sevinc, C ^a   Kiziler, A R ^b   Aydemir, B ^b   Titiz, I ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CHOLESTEROL; GLUCOSE; HEPATITIS C ANTIBODY;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER FUNCTION; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECIPIENT; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TURKEY (REPUBLIC);

ADULT; BILIRUBIN; BLOOD GLUCOSE; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HEPATITIS C; HUMANS; KIDNEY TRANSPLANTATION; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TURKEY;

EID: 33845429491     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.10.150     Document Type: Article

References (12)

1. Gane E., and Pilmore H. Management of chronic viral hepatitis before and after renal transplantation. Transplantation 74 (2002) 427
2. Bestard O., Cruzado J.M., Torras J., et al. Long-term effect of hepatitis C virus chronic infection on patient and renal graft survival. Transplant Proc 37 (2005) 3774
3. Einollahi B., Hajarizadeh B., Bakhtiari S., et al. Pretransplant hepatitis C virus infection and its effect on the post-transplant course of living renal allograft recipients. J Gastroenterol Hepatol 18 (2003) 836
4. Fabrizi F., Martin P., Dixit V., et al. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 5 (2005) 1452
5. Broumand B., Hakemi M.S., and Sabet M.S. Impact of hepatitis C virus infection on short-term outcomes in renal transplantation. Exp Clin Transplant 2 (2004) 242
6. Usta M., Dilek K., Ersoy A., et al. Prevalence of transfusion transmitted virus infection and its effect on renal graft survival in renal transplant recipients. Scand J Urol Nephrol 36 (2002) 473
7. Morales J.M., Dominguez-Gil B., Sanz-Guajardo D., et al. The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure. Nephrol Dial Transplant 19 (2004) 72
8. Breitenfeldt M.K., Rasenack J., Berthold H., et al. Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation. Clin Transplant 16 (2002) 130
9. Mahmoud I.M., Elhabashi A.F., Elsawy E., et al. The impact of hepatitis C virus viremia on renal graft and patient survival: a 9-year prospective study. Am J Kidney Dis 43 (2004) 131
10. Finni P.E., Souza E.R., Rioja S., et al. Is hepatitis C a risk factor to posttransplant diabetes mellitus after renal transplantation in patients using tacrolimus?. Transplant Proc 36 (2004) 884
11. Yildiz A., Tutuncu Y., Yazici H., et al. Association between hepatitis C virus infection and development of posttransplantation diabetes mellitus in renal transplant recipients. Transplantation 74 (2002) 1109
12. Lopez R., Gentil M.A., Acosta D., et al. Minimal model analysis in nondiabetic renal transplant recipients with hepatitis C. Transplant Proc 37 (2005) 1446